Trials / Unknown
UnknownNCT00498082
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome. The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.
Conditions
Timeline
- Start date
- 2007-09-01
- Completion
- 2008-09-01
- First posted
- 2007-07-09
- Last updated
- 2007-09-06
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00498082. Inclusion in this directory is not an endorsement.